LY2928057

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY2928057, covering 2019-02-07 to 2019-02-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2928057 in Hemodialysis Participants [Phase 1]